Researchers are exploring new treatment options for chronic myeloid leukemia (CML). Many treatments that have recently been studied or are currently under investigation are targeted therapy drugs.

Chronic myeloid leukemia (CML) has led the way for developing rational drug development in cancer. Most cases of CML diagnosed and treated in chronic phase are extremely well controlled with ...

白血病干细胞中获得性miR-142缺失与慢性髓性白血病母细胞危象相关。在这里，作者表明T细胞中获得性miR-142缺陷进一步使白血病干细胞逃避免疫监视并支持疾病生长。

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...

When Aaron von Freter learned he had chronic myeloid leukemia (CML), he “felt like the room was spinning,” he remembers. “I thought I’d been served a death sentence.” Aaron was 45 years old and had no ...

Chronic Myeloid Leukaemia (CML)is a type of Blood cancer. It is a disease of elderly but is seen in the age group of 30 yrs to 60 yrs too. Before 2001 , it was like a death sentence to patients ...

Various clinical trials have evaluated the clinical value of an initial dose intensification of imatinib in CML-CP patients (an overview of the most important response rates is given in Table 1).

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

Chronic myelogenous leukemia (CML) is a rare blood cancer caused by a chromosomal abnormality that produces an atypical gene. This gene drives the rapid proliferation of immature white blood cells, ...